Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Adamis Pharmaceuticl (ADMP)

0.8142   -0.035 (-4.09%) 04-14 08:04
Open: 0.8478 Pre. Close: 0.8489
High: 0.8499 Low: 0.76
Volume: 5,595,858 Market Cap: 114M
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.852 - 0.857 0.857 - 0.861
Low: 0.749 - 0.755 0.755 - 0.76
Close: 0.801 - 0.811 0.811 - 0.818

Technical analysis

as of: 2021-04-13 4:54:47 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.19     One year: 1.38
Support: Support1: 0.76    Support2: 0.63
Resistance: Resistance1: 1.02    Resistance2: 1.18
Pivot: 0.91
Moving Average: MA(5): 0.89     MA(20): 0.95
MA(100): 0.90     MA(250): 0.79
MACD: MACD(12,26): -0.06     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 11.49     %D(3): 17.33
RSI: RSI(14): 35.14
52-week: High: 2.34  Low: 0.32  Change(%): 126.2
Average Vol(K): 3-Month: 1879051  10-Days: 261581

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ADMP has closed below the lower band by 12.3%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 71.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADMP's normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 13 Apr 2021
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call and Business Update - Yahoo Finance

Tue, 13 Apr 2021
Adamis Pharmaceuticals : Provides an Update on ZIMHI - marketscreener.com

Mon, 12 Apr 2021
Adamis Pharma To Resubmit Zimhi US Application For Opioid Overdose Soon - Benzinga

Mon, 12 Apr 2021
Adamis Pharmaceuticals Provides an Update on ZIMHI™ - GlobeNewswire

Tue, 30 Mar 2021
Wait for Q4 Earnings Before Making Any Move on Adamis Pharmaceuticals Stock - InvestorPlace

Mon, 22 Mar 2021
Will Adamis Pharmaceuticals (ADMP) Report Negative Q4 Earnings? What You Should Know - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 140
Shares Float (M) 93
% Held by Insiders 0.63
% Held by Institutions 4.30
Shares Short (K) 4,030
Shares Short P. Month (K) 4,130

Stock Financials

EPS -0.499
EPS Est This Year -0.750
EPS Est Next Year -0.330
Book Value (p.s.) 0.290
Profit Margin -188.31
Operating Margin -157.94
Return on Assets (ttm) -37.6
Return on Equity (ttm) -102.5
Qtrly Rev. Growth -27.1
Gross Profit (p.s.) 0.045
Sales Per Share 0.131
EBITDA (p.s.) -0.183
Qtrly Earnings Growth
Operating Cash Flow (M) -18
Levered Free Cash Flow (M) -9

Stock Valuations

PE Ratio -1.63
PEG Ratio
Price to Book value 2.81
Price to Sales 6.20
Price to Cash Flow -6.20

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.